Freedom SOLO Stentless Heart Valve Study
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 251 participants.
Also called NCT01115907
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 251 participants
- Sponsor
- Sorin Group USA, Inc.
- Registry
-
NCT01115907
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01115907. Allocation not applicable; no masking; primary purpose treatment. Start 2010-12 (registry gives no type); primary completion 2014-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Freedom SOLO Stentless Heart Valve Study
- Acronym
- SOLO
- Condition
- Aortic Stenosis
- Condition
- Aortic Insufficiency
- Intervention (Device)
- Freedom SOLO Stentless Heart Valve
- Lead sponsor
- Sorin Group USA, Inc.
Record details
- Record id
cardio:ct-nct01115907- Content hash
7c81833b12a0bdc6b6f8d9cc224e8cae6411a4acb1ef0b5059fbff168b0e1e60